{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:48:10Z","timestamp":1765039690516,"version":"build-2065373602"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T00:00:00Z","timestamp":1685750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T00:00:00Z","timestamp":1685750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010252","name":"\u015al\u0105ski Uniwersytet Medyczny w Katowicach","doi-asserted-by":"publisher","award":["KNW-1-186\/N\/8\/K","KNW\u20111\u2011158\/K\/5\/0","KNW\u20111\u2011056\/N\/4\/0","KNW\u20111\u2011135\/N\/3\/0"],"award-info":[{"award-number":["KNW-1-186\/N\/8\/K","KNW\u20111\u2011158\/K\/5\/0","KNW\u20111\u2011056\/N\/4\/0","KNW\u20111\u2011135\/N\/3\/0"]}],"id":[{"id":"10.13039\/501100010252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:p>The effects of specific cytokines produced by T cell subsets (such as Th1, Th2, and newly discovered Th17, Treg, Tfh, or Th22) are diverse, depending on interactions with other cytokines, distinct signaling pathways, phase of the disease, or etiological factor. The immunity equilibrium of the immune cells, such as the Th1\/Th2, the Th17\/Treg, and the Th17\/Th1 balance is necessary for the maintenance of the immune homeostasis. If the balance of the T cells subsets is damaged, the autoimmune response becomes enhanced which leads to autoimmune diseases. Indeed, both the Th1\/Th2 and the Th17\/Treg dichotomies are involved in the pathomechanism of autoimmune diseases. The aim of the study was to determine the cytokines of Th17 lymphocytes as well as the factors modulating their activity in patients with pernicious anemia. The magnetic bead-based immunoassays used (Bio-Plex) allow simultaneous detection of multiple immune mediators from one serum sample. In our study, we showed that patients suffering from pernicious anemia develop the Th1\/Th2 imbalance with a quantitative advantage of cytokines participating in Th1-related immune response, the Th17\/Treg imbalance with a quantitative advantage of cytokines participating in Treg-related response, as well as the Th17\/Th1 imbalance with a quantitative predominance of cytokines participating in Th1-related immune response. Our study results indicate that T lymphocytes and their specific cytokines play an role in the course of pernicious anemia. The observed changes may indicate the immune response to pernicious anemia or be an element of the pernicious anemia pathomechanism.<\/jats:p>","DOI":"10.1007\/s12026-023-09399-9","type":"journal-article","created":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T13:01:52Z","timestamp":1685797312000},"page":"873-882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Th17 cytokines and factors modulating their activity in patients with pernicious anemia"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5577-800X","authenticated-orcid":false,"given":"Dariusz","family":"Kajdaniuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1453-5087","authenticated-orcid":false,"given":"Wanda","family":"Foltyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Morawiec-Szymonik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8216-4495","authenticated-orcid":false,"given":"Zenon","family":"Czuba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Szymonik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3755-1722","authenticated-orcid":false,"given":"Beata","family":"Kos-Kud\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5958-1338","authenticated-orcid":false,"given":"Bogdan","family":"Marek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,3]]},"reference":[{"key":"9399_CR1","first-page":"19","volume":"95","author":"M Schwartz","year":"1967","unstructured":"Schwartz M. Antibody to intrinsic factor. Scand J Clin Lab Invest Suppl. 1967;95:19\u201327.","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"9399_CR2","first-page":"159","volume":"19","author":"CM Rojas Hernandez","year":"2015","unstructured":"Rojas Hernandez CM, Oo TH. Advances in mechanisms, diagnosis, and treatment of pernicious anemia. Discov Med. 2015;19:159\u201368.","journal-title":"Discov Med"},{"key":"9399_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000362356","volume":"133","author":"S Watanabe","year":"2015","unstructured":"Watanabe S, Ide N, Ogawara H, Yokohama A, Mitsui T, Handa H, et al. High percentage of regulatory T cells before and after vitamin B12 treatment in patients with pernicious anemia. Acta Haematol. 2015;133:83\u20138. https:\/\/doi.org\/10.1159\/000362356.","journal-title":"Acta Haematol"},{"key":"9399_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.advms.2015.12.004","volume":"61","author":"E Rusak","year":"2016","unstructured":"Rusak E, Chobot A, Krzywicka A, Wenzlau J. Anti-parietal cell antibodies \u2013 diagnostic significance. Adv Med Sci. 2016;61:175\u20139. https:\/\/doi.org\/10.1016\/j.advms.2015.12.004.","journal-title":"Adv Med Sci"},{"key":"9399_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5603\/EP.a2018.0086","volume":"70","author":"E Morawiec-Szymonik","year":"2019","unstructured":"Morawiec-Szymonik E, Foltyn W, Marek B, Kos-Kud\u0142a B, Kajdaniuk D. Pernicious anaemia and endocrine glands antibodies. Endokrynol Pol. 2019;70:143\u201350. https:\/\/doi.org\/10.5603\/EP.a2018.0086.","journal-title":"Endokrynol Pol"},{"key":"9399_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.20452\/pamw.15094","volume":"130","author":"E Morawiec-Szymonik","year":"2020","unstructured":"Morawiec-Szymonik E, Foltyn W, Marek B, G\u0142ogowska-Szel\u0105g J, Kos-Kud\u0142a B, Kajdaniuk D. Antibodies involved in the development of pernicious anemia and other autoimmune diseases. Pol Arch Intern Med. 2020;130:31\u20137. https:\/\/doi.org\/10.20452\/pamw.15094.","journal-title":"Pol Arch Intern Med"},{"key":"9399_CR7","first-page":"362","volume-title":"Immunologia","author":"D Nowis","year":"2019","unstructured":"Nowis D, Wa\u0144kowicz-Kali\u0144ska A, Winiarska M. Zjawiska autoimmunizacyjne. In: Go\u0142\u0105b J, Jak\u00f3bisiak M, Lasek W, Stok\u0142osa T, editors. Immunologia. Warszawa: PWN; 2019. p. 362\u201382."},{"key":"9399_CR8","doi-asserted-by":"publisher","first-page":"286","DOI":"10.5603\/EP.a2021.0035","volume":"72","author":"A Decmann","year":"2021","unstructured":"Decmann A, T\u0151ke J, Cs\u00f6regh \u00c9, G\u00e1sp\u00e1rdy G, Somogyi A. Type 3 autoimmune polyglandular syndrome with multiple genetic alterations in a young male patient with type 1 diabetes mellitus. Endokrynol Pol. 2021;72:286\u20137. https:\/\/doi.org\/10.5603\/EP.a2021.0035.","journal-title":"Endokrynol Pol"},{"key":"9399_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.5603\/EP.a2021.0076","volume":"72","author":"S Janyga","year":"2021","unstructured":"Janyga S, Marek B, Kajdaniuk D, Ogrodowczyk-Bobik M, Urbanek A, Bu\u0142dak \u0141. CD4+ cells in autoimmune thyroid disease. Endokrynol Pol. 2021;72:572\u201383. https:\/\/doi.org\/10.5603\/EP.a2021.0076.","journal-title":"Endokrynol Pol"},{"key":"9399_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nri2295","volume":"8","author":"D Chen","year":"2008","unstructured":"Chen D. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol. 2008;8:337\u201348. https:\/\/doi.org\/10.1038\/nri2295.","journal-title":"Nat Rev Immunol"},{"key":"9399_CR11","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. 2005;6:1123\u201332. https:\/\/doi.org\/10.1038\/ni1254.","journal-title":"Nat Immunol"},{"key":"9399_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1084\/jem.20041257","volume":"201","author":"CL Langrish","year":"2005","unstructured":"Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201:233\u201340. https:\/\/doi.org\/10.1084\/jem.20041257.","journal-title":"J Exp Med"},{"key":"9399_CR13","doi-asserted-by":"publisher","first-page":"819467","DOI":"10.1155\/2012\/819467","volume":"2012","author":"JC Waite","year":"2012","unstructured":"Waite JC, Skokos D. Th17 response and inflammatory autoimmune diseases. Int J Inflam. 2012;2012:819467. https:\/\/doi.org\/10.1155\/2012\/819467.","journal-title":"Int J Inflam"},{"key":"9399_CR14","doi-asserted-by":"publisher","first-page":"19408","DOI":"10.1073\/pnas.2005010117","volume":"117","author":"MP Crawford","year":"2020","unstructured":"Crawford MP, Sinha S, Renavikar PS, Borcherding N, Karandikar NJ. CD4 T cell-intrinsic role for the T helper 17 signature cytokine IL-17: Effector resistance to immune suppression. Proc Natl Acad Sci U S A. 2020;117:19408\u201314. https:\/\/doi.org\/10.1073\/pnas.2005010117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9399_CR15","first-page":"159","volume-title":"Immunologia","author":"J Go\u0142\u0105b","year":"2019","unstructured":"Go\u0142\u0105b J, Jak\u00f3bisiak M, Firczuk M. Cytokiny. In: Go\u0142\u0105b J, Jak\u00f3bisiak M, Lasek W, Stok\u0142osa T, editors. Immunologia. Warszawa: PWN; 2019. p. 159\u201398."},{"key":"9399_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature07021","volume":"454","author":"L Yang","year":"2008","unstructured":"Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, et al. IL-21 and TGF-\u03b2 are required for differentiation of human T(H)17 cells. Nature. 2008;454:350\u20132. https:\/\/doi.org\/10.1038\/nature07021.","journal-title":"Nature"},{"key":"9399_CR17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","volume":"30","author":"Y Chung","year":"2009","unstructured":"Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Soon Kang H, et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity. 2009;30:576\u201387. https:\/\/doi.org\/10.1016\/j.immuni.2009.02.007.","journal-title":"Immunity"},{"key":"9399_CR18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","volume":"31","author":"CE Sutton","year":"2009","unstructured":"Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KHG. Interleukin-1 and IL-23 induce innate IL-17 production from \u03b3\u03b4 T cells, amplifying Th17 responses and autoimmunity. Immunity. 2009;31:331\u201341. https:\/\/doi.org\/10.1016\/j.immuni.2009.08.001.","journal-title":"Immunity"},{"key":"9399_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cytogfr.2010.10.006","volume":"21","author":"K Hirahara","year":"2010","unstructured":"Hirahara K, Ghoreschi K, Laurence A, Yang X-P, Kanno Y, O\u2019Shea JJ. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine Growth Factor Rev. 2010;21:425\u201334. https:\/\/doi.org\/10.1016\/j.cytogfr.2010.10.006.","journal-title":"Cytokine Growth Factor Rev"},{"key":"9399_CR20","doi-asserted-by":"publisher","first-page":"106187","DOI":"10.1016\/j.intimp.2020.106187","volume":"80","author":"B Wu","year":"2020","unstructured":"Wu B, Wan Y. Molecular control of pathogenic Th17 cells in autoimmune diseases. Int Immunopharmacol. 2020;80:106187. https:\/\/doi.org\/10.1016\/j.intimp.2020.106187.","journal-title":"Int Immunopharmacol"},{"key":"9399_CR21","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1084\/jem.20082286","volume":"206","author":"J Das","year":"2009","unstructured":"Das J, Ren G, Zhang L, Roberts AI, Zhao X, Bothwell ALM, et al. Transforming growth factor \u03b2 is dispensable for the molecular orchestration of Th17 cell differentiation. J Exp Med. 2009;206:2407\u201316. https:\/\/doi.org\/10.1084\/jem.20082286.","journal-title":"J Exp Med"},{"key":"9399_CR22","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nature09447","volume":"467","author":"K Ghoreschi","year":"2010","unstructured":"Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, et al. Generation of pathogenic T(H)17 cells in the absence of TGF-\u03b2 signalling. Nature. 2010;467:967\u201371. https:\/\/doi.org\/10.1038\/nature09447.","journal-title":"Nature"},{"key":"9399_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2019.01.013","volume":"99","author":"D Long","year":"2019","unstructured":"Long D, Chen Y, Wu H, Zhao M, Lu Q. Clinical significance and immunobiology of IL-21 in autoimmunity. J Autoimmun. 2019;99:1\u201314. https:\/\/doi.org\/10.1016\/j.jaut.2019.01.013.","journal-title":"J Autoimmun"},{"key":"9399_CR24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature05969","volume":"448","author":"R Nurieva","year":"2007","unstructured":"Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 2007;448:480\u20133. https:\/\/doi.org\/10.1038\/nature05969.","journal-title":"Nature"},{"key":"9399_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000452541","volume":"40","author":"C Li","year":"2016","unstructured":"Li C, Yuan J, Zhu YF, Yang XJ, Wang Q, Xu J, et al. Imbalance of Th17\/Treg in different subtypes of autoimmune thyroid diseases. Cell Physiol Biochem. 2016;40:245\u201352. https:\/\/doi.org\/10.1159\/000452541.","journal-title":"Cell Physiol Biochem"},{"key":"9399_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12020-017-1361-y","volume":"57","author":"M Vitales-Noyola","year":"2017","unstructured":"Vitales-Noyola M, Ramos-Levi AM, Mart\u00ednez-Hern\u00e1ndez R, Serrano-Somavilla A, Sampedro-Nu\u00f1ez M, Gonz\u00e1lez-Amaro R, et al. Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders. Endocrine. 2017;57:409\u201317. https:\/\/doi.org\/10.1007\/s12020-017-1361-y.","journal-title":"Endocrine"},{"key":"9399_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1507\/endocrj.EJ18-0396","volume":"66","author":"T Zake","year":"2019","unstructured":"Zake T, Skuja S, Kalere I, Konrade I, Groma V. Upregulated tissue expression of T helper (Th) 17 pathogenic interleukin (IL)-23 and IL-1\u03b2 in Hashimoto\u2019s thyroiditis but not in Graves\u2019 disease. Endocr J. 2019;66:423\u201330. https:\/\/doi.org\/10.1507\/endocrj.EJ18-0396.","journal-title":"Endocr J"},{"key":"9399_CR28","doi-asserted-by":"publisher","first-page":"119223","DOI":"10.1016\/j.bbamcr.2022.119223","volume":"1869","author":"G Le Menn","year":"2022","unstructured":"Le Menn G, Jab\u0142o\u0144ska A, Chen Z. The effects of post-translational modifications on Th17\/Treg cell differentiation. Biochim Biophys Acta Mol Cell Res. 2022;1869:119223. https:\/\/doi.org\/10.1016\/j.bbamcr.2022.119223.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"9399_CR29","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/jcp.27180","volume":"234","author":"Q Li","year":"2019","unstructured":"Li Q, Wang B, Mu K, Zhang J-A. The pathogenesis of thyroid autoimmune diseases: New T lymphocytes - Cytokines circuits beyond the Th1-Th2 paradigm. J Cell Physiol. 2019;234:2204\u201316. https:\/\/doi.org\/10.1002\/jcp.27180.","journal-title":"J Cell Physiol"},{"key":"9399_CR30","doi-asserted-by":"publisher","first-page":"782935","DOI":"10.3389\/fimmu.2021.782935","volume":"12","author":"K Hendrawan","year":"2022","unstructured":"Hendrawan K, Khoo MLM, Visweswaran M, Massey JC, Withers B, Sutton I, et al. Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation. Front Immunol. 2022;12:782935. https:\/\/doi.org\/10.3389\/fimmu.2021.782935.","journal-title":"Front Immunol"},{"key":"9399_CR31","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.2147\/JIR.S355881","volume":"15","author":"K Singh","year":"2022","unstructured":"Singh K, Rathore U, Rai MK, Behera MR, Jain N, Ora M, et al. Novel Th17 lymphocyte populations, Th17.1 and PD1+Th17, are increased in Takayasu arteritis, and both Th17 and Th17.1 sub-populations associate with active disease. J Inflamm Res. 2022;15:1521\u201341. https:\/\/doi.org\/10.2147\/JIR.S355881.","journal-title":"J Inflamm Res"},{"key":"9399_CR32","doi-asserted-by":"publisher","first-page":"103017","DOI":"10.1016\/j.autrev.2021.103017","volume":"21","author":"H Nakase","year":"2022","unstructured":"Nakase H, Sato N, Mizuno N, Ikawa Y. The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmun Rev. 2022;21:103017. https:\/\/doi.org\/10.1016\/j.autrev.2021.103017.","journal-title":"Autoimmun Rev"},{"key":"9399_CR33","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s12026-022-09296-7","volume":"70","author":"R Fakhfakh","year":"2022","unstructured":"Fakhfakh R, Zian Z, Elloumi N, Abida O, Bouallegui E, Houssaini H, et al. Th17 and Th1 cells in systemic lupus erythematosus with focus on lupus nephritis. Immunol Res. 2022;70:644\u201353. https:\/\/doi.org\/10.1007\/s12026-022-09296-7.","journal-title":"Immunol Res"},{"key":"9399_CR34","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.18632\/oncotarget.26874","volume":"10","author":"A Troilo","year":"2019","unstructured":"Troilo A, Grassi A, Petrone L, Cianchi F, Benagiano M, Bella CD, et al. Intrinsic factor recognition promotes T helper 17\/T helper 1 autoimmune gastric inflammation in patients with pernicious anemia. Oncotarget. 2019;10:2921\u20139. https:\/\/doi.org\/10.18632\/oncotarget.26874.","journal-title":"Oncotarget"},{"key":"9399_CR35","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1080\/1547691X.2016.1184360","volume":"13","author":"M Dobrakowski","year":"2016","unstructured":"Dobrakowski M, Boro\u0144 M, Czuba ZP, Kasperczyk A, Macho\u0144-Grecka A, Kasperczyk S. Cytokines related to three major types of cell-mediated immunity in short- and long-term exposures to lead compounds. J Immunotoxicol. 2016;13:770\u20134. https:\/\/doi.org\/10.1080\/1547691X.2016.1184360.","journal-title":"J Immunotoxicol"},{"key":"9399_CR36","doi-asserted-by":"publisher","first-page":"7161346","DOI":"10.1155\/2018\/7161346","volume":"2018","author":"E Grudzi\u0144ska","year":"2018","unstructured":"Grudzi\u0144ska E, Lekstan A, Szliszka E, Czuba ZP. Cytokines produced by lymphocytes in the incompetent great saphenous vein. Mediators Inflamm. 2018;2018:7161346. https:\/\/doi.org\/10.1155\/2018\/7161346.","journal-title":"Mediators Inflamm"},{"key":"9399_CR37","doi-asserted-by":"publisher","first-page":"7057303","DOI":"10.1155\/2019\/7057303","volume":"2019","author":"E Grudzi\u0144ska","year":"2019","unstructured":"Grudzi\u0144ska E, Grzegorczyn S, Czuba ZP. Chemokines and growth factors produced by lymphocytes in the incompetent great saphenous vein. Mediators Inflamm. 2019;2019:7057303. https:\/\/doi.org\/10.1155\/2019\/7057303.","journal-title":"Mediators Inflamm"},{"key":"9399_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13071-020-4003-9","volume":"13","author":"ZD Li","year":"2020","unstructured":"Li ZD, Mo XJ, Yan S, Wang D, Xu B, Guo J, et al. Multiplex cytokine and antibody profile in cystic echinococcosis patients during a three-year follow-up in reference to the cyst stages. Parasit Vectors. 2020;13:133. https:\/\/doi.org\/10.1186\/s13071-020-4003-9.","journal-title":"Parasit Vectors"},{"key":"9399_CR39","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3109\/08923973.2011.619987","volume":"34","author":"F Jadidi-Niaragh","year":"2012","unstructured":"Jadidi-Niaragh F, Mirshafiey A. The deviated balance between regulatory T cell and Th17 in autoimmunity. Immunopharmacol Immunotoxicol. 2012;34:727\u201339. https:\/\/doi.org\/10.3109\/08923973.2011.619987.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"9399_CR40","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.cell.2016.10.026","volume":"167","author":"L Chen","year":"2016","unstructured":"Chen L, Ge B, Casale FP, Vasquez L, Kwan T, Garrido-Mart\u00edn D, et al. Genetic drivers of epigenetic and transcriptional variation in human immune cells. Cell. 2016;167:1398-1414.e24. https:\/\/doi.org\/10.1016\/j.cell.2016.10.026.","journal-title":"Cell"},{"key":"9399_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.lfs.2017.11.026","volume":"192","author":"S Shao","year":"2018","unstructured":"Shao S, Yu X, Shen L. Autoimmune thyroid diseases and Th17\/Treg lymphocytes. Life Sci. 2018;192:160\u20135. https:\/\/doi.org\/10.1016\/j.lfs.2017.11.026.","journal-title":"Life Sci"},{"key":"9399_CR42","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s12020-015-0759-7","volume":"52","author":"R Gonz\u00e1lez-Amaro","year":"2016","unstructured":"Gonz\u00e1lez-Amaro R, Marazuela M. T regulatory (Treg) and T helper 17 (Th17) lymphocytes in thyroid autoimmunity. Endocrine. 2016;52:30\u20138. https:\/\/doi.org\/10.1007\/s12020-015-0759-7.","journal-title":"Endocrine"},{"key":"9399_CR43","doi-asserted-by":"publisher","first-page":"8431838","DOI":"10.1155\/2017\/8431838","volume":"2017","author":"J Qin","year":"2017","unstructured":"Qin J, Zhou J, Fan C, Zhao N, Liu Y, Wang S, et al. Increased circulating Th17 but decreased CD4+Foxp3+ Treg and CD19+CD1dhiCD5+ Breg subsets in new-onset Graves\u2019 disease. Biomed Res Int. 2017;2017:8431838. https:\/\/doi.org\/10.1155\/2017\/8431838.","journal-title":"Biomed Res Int"},{"key":"9399_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1507\/endocrj.EJ19-0307","volume":"67","author":"Z Chen","year":"2020","unstructured":"Chen Z, Wang Y, Ding X, Zhang M, He M, Zhao Y, et al. The proportion of peripheral blood Tregs among the CD4+ T cells of autoimmune thyroid disease patients: a meta-analysis. Endocr J. 2020;67:317\u201326. https:\/\/doi.org\/10.1507\/endocrj.EJ19-0307.","journal-title":"Endocr J"},{"key":"9399_CR45","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.1038\/s41598-022-07075-w","volume":"12","author":"J Aarts","year":"2022","unstructured":"Aarts J, van Caam A, Chen X, Marijnissen RJ, Helsen MM, Walgreen B, et al. Local inhibition of TGF-\u03b21 signaling improves Th17\/Treg balance but not joint pathology during experimental arthritis. Sci Rep. 2022;12:3182. https:\/\/doi.org\/10.1038\/s41598-022-07075-w.","journal-title":"Sci Rep"},{"key":"9399_CR46","doi-asserted-by":"publisher","first-page":"C699","DOI":"10.1152\/ajpcell.00376.2021","volume":"322","author":"M Honda","year":"2022","unstructured":"Honda M, Segawa T, Ishikawa K, Maeda M, Saito Y, Kon S. Nephronectin influences EAE development by regulating the Th17\/Treg balance via reactive oxygen species. Am J Physiol Cell Physiol. 2022;322:C699\u2013711. https:\/\/doi.org\/10.1152\/ajpcell.00376.2021.","journal-title":"Am J Physiol Cell Physiol"},{"key":"9399_CR47","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/gast.2001.21187","volume":"120","author":"MM D'Elios","year":"2001","unstructured":"D\u2019Elios MM, Bergman MP, Azzurri A, Amedei A, Benagiano M, De Pont JJ, et al. H(+), K(+)-atpase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology. 2001;120:377\u201386. https:\/\/doi.org\/10.1053\/gast.2001.21187.","journal-title":"Gastroenterology"},{"key":"9399_CR48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s40618-016-0575-9","volume":"40","author":"Q Yuan","year":"2017","unstructured":"Yuan Q, Zhao Y, Zhu X, Liu X. Low regulatory T cell and high IL-17 mRNA expression in a mouse Graves\u2019 disease model. J Endocrinol Invest. 2017;40:397\u2013407. https:\/\/doi.org\/10.1007\/s40618-016-0575-9.","journal-title":"J Endocrinol Invest"},{"key":"9399_CR49","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1210\/jc.2010-1424","volume":"96","author":"GJ Kahaly","year":"2011","unstructured":"Kahaly GJ, Shimony O, Gellman YN, Lytton SD, Eshkar-Sebban L, Rosenblum N, et al. Regulatory T-cells in Graves\u2019 orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin. J Clin Endocrinol Metab. 2011;96:422\u20139. https:\/\/doi.org\/10.1210\/jc.2010-1424.","journal-title":"J Clin Endocrinol Metab"},{"key":"9399_CR50","doi-asserted-by":"publisher","first-page":"198","DOI":"10.5603\/EP.a2019.0067","volume":"71","author":"M \u015awierkot","year":"2020","unstructured":"\u015awierkot M, Kulawik G, Sarnat-Kucharczyk M, Jagoda K, Mrukwa-Kominek E, Chudek J. Long-term remission of steroid-resistant Graves\u2019 orbitopathy after administration of anti-thymocyte globulin. Endokrynol Pol. 2020;71:198\u20139. https:\/\/doi.org\/10.5603\/EP.a2019.0067.","journal-title":"Endokrynol Pol"},{"key":"9399_CR51","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1210\/jc.2018-00498","volume":"103","author":"M Vitales-Noyola","year":"2018","unstructured":"Vitales-Noyola M, Serrano-Somavilla A, Mart\u00ednez-Hern\u00e1ndez R, Sampedro-Nu\u00f1ez M, Ramos-Levi AM, Gonz\u00e1lez-Amaro R, et al. Patients with autoimmune thyroiditis show diminished levels and defective suppressive function of Tr1 regulatory lymphocytes. J Clin Endocrinol Metab. 2018;103:3359\u201367. https:\/\/doi.org\/10.1210\/jc.2018-00498.","journal-title":"J Clin Endocrinol Metab"},{"key":"9399_CR52","doi-asserted-by":"publisher","first-page":"384","DOI":"10.5603\/EP.2013.0022","volume":"64","author":"D Kajdaniuk","year":"2013","unstructured":"Kajdaniuk D, Marek B, Borgiel-Marek H, Kos-Kud\u0142a B. Transforming growth factor \u03b21 (TGF\u03b21) in physiology and pathology. Endokrynol Pol. 2013;64:384\u201396. https:\/\/doi.org\/10.5603\/EP.2013.0022.","journal-title":"Endokrynol Pol"},{"key":"9399_CR53","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"22","author":"S Sakaguchi","year":"2004","unstructured":"Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531\u201362. https:\/\/doi.org\/10.1146\/annurev.immunol.21.120601.141122.","journal-title":"Annu Rev Immunol"},{"key":"9399_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4049\/jimmunol.1502344","volume":"197","author":"J Harakal","year":"2016","unstructured":"Harakal J, Rival C, Qiao H, Tung KS. Regulatory T cells control Th2-dominant murine autoimmune gastritis. J Immunol. 2016;197:27\u201341. https:\/\/doi.org\/10.4049\/jimmunol.1502344.","journal-title":"J Immunol"},{"key":"9399_CR55","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1210\/jc.2005-2337","volume":"91","author":"M Marazuela","year":"2006","unstructured":"Marazuela M, Garc\u00eda-L\u00f3pez MA, Figueroa-Vega N, de la Fuente H, Alvarado-S\u00e1nchez B, Monsiv\u00e1is-Urenda A, et al. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab. 2006;91:3639\u201346. https:\/\/doi.org\/10.1210\/jc.2005-2337.","journal-title":"J Clin Endocrinol Metab"},{"key":"9399_CR56","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s12020-015-0662-2","volume":"51","author":"A Rodr\u00edguez-Mu\u00f1oz","year":"2016","unstructured":"Rodr\u00edguez-Mu\u00f1oz A, Vitales-Noyola M, Ramos-Levi A, Serrano-Somavilla A, Gonz\u00e1lez-Amaro R, Marazuela M. Levels of regulatory T cells CD69(+)NKG2D(+)IL-10(+) are increased in patients with autoimmune thyroid disorders. Endocrine. 2016;51:478\u201389. https:\/\/doi.org\/10.1007\/s12020-015-0662-2.","journal-title":"Endocrine"},{"key":"9399_CR57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/cyto.a.22348","volume":"85","author":"L Cosmi","year":"2014","unstructured":"Cosmi L, Maggi L, Santarlasci V, Liotta F, Annunziato F. T helper cells plasticity in inflammation: T Helper Cells Plasticity in Inflammation. Cytometry A. 2014;85:36\u201342. https:\/\/doi.org\/10.1002\/cyto.a.22348.","journal-title":"Cytometry A"},{"key":"9399_CR58","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3389\/fimmu.2014.00630","volume":"5","author":"J Geginat","year":"2014","unstructured":"Geginat J, Paroni M, Maglie S, Alfen JS, Kastirr I, Gruarin P, et al. Plasticity of human CD4 T cell subsets. Front Immunol. 2014;5:630. https:\/\/doi.org\/10.3389\/fimmu.2014.00630.","journal-title":"Front Immunol"},{"key":"9399_CR59","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.intimp.2015.03.050","volume":"28","author":"W Ellmeier","year":"2015","unstructured":"Ellmeier W. Molecular control of CD4(+) T cell lineage plasticity and integrity. Int Immunopharmacol. 2015;28:813\u20137. https:\/\/doi.org\/10.1016\/j.intimp.2015.03.050.","journal-title":"Int Immunopharmacol"},{"key":"9399_CR60","doi-asserted-by":"publisher","first-page":"314620","DOI":"10.1155\/2015\/314620","volume":"2015","author":"L Gu\u00e9ry","year":"2015","unstructured":"Gu\u00e9ry L, Hugues S. Th17 Cell Plasticity and Functions in Cancer Immunity. Biomed Res Int. 2015;2015:314620. https:\/\/doi.org\/10.1155\/2015\/314620.","journal-title":"Biomed Res Int"},{"key":"9399_CR61","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nri.2015.18","volume":"16","author":"M DuPage","year":"2016","unstructured":"DuPage M, Bluestone JA. Harnessing the plasticity of CD4+T cells to treat immune-mediated disease. Nat Rev Immunol. 2016;16:149\u201363. https:\/\/doi.org\/10.1038\/nri.2015.18.","journal-title":"Nat Rev Immunol"},{"key":"9399_CR62","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1002\/eji.201646618","volume":"46","author":"J Geginat","year":"2016","unstructured":"Geginat J, Paroni M, Kastirr I, Larghi P, Pagani M, Abrignani S. Reverse plasticity: TGF-beta and IL-6 induce Th1-to-Th17-cell transdifferentiation in the gut. Eur J Immunol. 2016;46:2306\u201310. https:\/\/doi.org\/10.1002\/eji.201646618.","journal-title":"Eur J Immunol"},{"key":"9399_CR63","doi-asserted-by":"publisher","first-page":"e68446","DOI":"10.1371\/journal.pone.0068446","volume":"8","author":"D Peng","year":"2013","unstructured":"Peng D, Xu B, Wang Y, Guo H, Jiang Y. A high frequency of circulating th22 and th17 cells in patients with new onset graves\u2019 disease. PLoS One. 2013;8:e68446. https:\/\/doi.org\/10.1371\/journal.pone.0068446.","journal-title":"PLoS One"},{"key":"9399_CR64","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1507\/endocrj.ej13-0484","volume":"61","author":"RM Ruggeri","year":"2014","unstructured":"Ruggeri RM, Saitta S, Cristani M, Giovinazzo S, Tigano V, Trimarchi F, et al. Serum interleukin-23 (IL-23) is increased in Hashimoto\u2019s thyroiditis. Endocr J. 2014;61:359\u201363. https:\/\/doi.org\/10.1507\/endocrj.ej13-0484.","journal-title":"Endocr J"},{"key":"9399_CR65","doi-asserted-by":"publisher","first-page":"952674","DOI":"10.3389\/fimmu.2022.952674","volume":"13","author":"C Della Bella","year":"2022","unstructured":"Della Bella C, Antico A, Panozzo MP, Capitani N, Petrone L, Benagiano M, et al. Gastric Th17 Cells Specific for H+\/K+-ATPase and Serum IL-17 Signature in Gastric Autoimmunity. Front Immunol. 2022;13:952674. https:\/\/doi.org\/10.3389\/fimmu.2022.952674.","journal-title":"Front Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-023-09399-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-023-09399-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-023-09399-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T08:08:14Z","timestamp":1700726894000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-023-09399-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,3]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["9399"],"URL":"https:\/\/doi.org\/10.1007\/s12026-023-09399-9","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"type":"print","value":"0257-277X"},{"type":"electronic","value":"1559-0755"}],"subject":[],"published":{"date-parts":[[2023,6,3]]},"assertion":[{"value":"30 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}